The Effects of Acute Exercise on Glucose Kinetics, Beta-cell Function and the Incretin Effect in Subjects Representative of the Whole Glucose Tolerance Continuum
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Rigshospitalet, Denmark
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Glucose tolerance
Study Overview
Brief Summary
Human volunteers will be stratified by oral glucose tolerance status: normal glucose tolerant, impaired glucose tolerant, and type 2 diabetic. All subjects will undergo 4 experimental trials: [1] an oral glucose tolerance test (OGTT) combined with infused and ingested stable isotopes of glucose to assess glucose kinetics. [2] a 1 hour bout of cycling exercise at 50% of maximum power output, immediately followed by the same OGTT combined with stable isotope glucose tracers used in trial 1. [3] an isoglycemic clamp to match the plasma glucose profile measured in trial 1. [4] a 1 hour bout of cycling exercise at 50% of maximum power output, immediately followed by an isoglycemic clamp to match the plasma glucose profile measured in trial 2.
Exercise-induced changes in oral glucose tolerance, glucose kinetics, insulin and glucagon secretion, and the incretin effect will be examined. The exercise responses will be compared between the subjects groups of different glucose tolerance status.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •age 18-60 years
- •BMI 18-35 kg/m2
Exclusion Criteria
- •insulin dependency
- •pregnancy
- •presence or history of chronic cardiovascular, pulmonary, hepatic, renal, or hematological disease, or cancer
- •contraindication to physical activity as assessed by ECG
Arms & Interventions
Resting Trial
a 1 hour period of rest immediately prior to OGTT or isoglycemic clamp
Exercise Trial
a 1 hour cycling exercise bout immediately prior to the OGTT or isoglycemic clamp
Intervention: Exercise (Behavioral)
Outcomes
Primary Outcomes
Glucose tolerance
Time Frame: Plasma glucose will be measured at 10 minute intervals during the OGTT (3 hours) immediately following the period of rest or exercise
Incretin effect
Time Frame: Plasma insulin and C-peptide will be measured at 10 minute intervals during the OGTT (3 hours) and isoglycemic clamp (3 hours) immediately following the period of rest or exercise
Secondary Outcomes
No secondary outcomes reported
Investigators
Thomas Solomon
Senior Researcher
Rigshospitalet, Denmark
